XML 21 R2.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2021
Mar. 31, 2020
Current assets:    
Cash and cash equivalents $ 182,518 $ 59,500
Short-term investments 293,784 109,055
Research and development incentives receivable 2,953 2,962
Prepaid expenses and other current assets 4,492 2,734
Total current assets 483,747 174,251
Property, plant and equipment, net 7,442 6,860
Restricted cash 1,636 1,636
Right-to-use asset-operating leases 5,751 4,425
Right-to-use asset-financing leases 44,522 46,925
Total assets 543,098 234,097
Current liabilities:    
Accounts payable 2,355 3,434
Accrued expenses and other current liabilities 8,735 5,156
Operating lease liabilities, current 970 873
Financing lease liabilities, current 2,487 2,411
Total current liabilities 14,547 11,874
Long term debt, net of debt discount   9,801
Operating lease liabilities, non-current 5,078 3,737
Financing lease liabilities, non-current 24,745 24,967
Total liabilities 44,370 50,379
Commitments and contingencies (Note 12)
Stockholders' Equity    
Common stock, $0.001 par value; 150,000,000 shares authorized as of March 31, 2021 and March 31, 2020; 46,566,481 and 36,668,743 shares issued and outstanding as of March 31, 2021 and March 31, 2020, respectively 47 37
Additional paid-in capital 692,243 296,961
Accumulated deficit (193,168) (112,298)
Accumulated other comprehensive loss (394) (982)
Total stockholders' equity 498,728 183,718
Total liabilities and stockholders' equity $ 543,098 $ 234,097